Article
In a survey released by Community Oncology Alliance (COA), the majority of physicians reported concern over proposals to reform the Medicare Part B program
In a survey released by Community Oncology Alliance (COA), the majority of physicians reported concern over proposals to reform the Medicare Part B program. The survey included 100 oncologists/hematologists and 50 rheumatologists. COA commissioned the survey to gain insight into physician perspectives of 2 proposals set forth by the Medicare Payment Advisory Commission and mentioned by President Donald Trump in his blueprint to lower drug prices and out-of-pocket costs.
The survey inquired about opinions on the revamped Competitive Acquisition Program, in which select private vendors would negotiate drug prices with manufacturers, and a proposal to shift prescription drugs currently paid under Medicare Part B into the Medicare Part D program.
Physicians indicated that they are worried the proposed changes would reduce care choices, increase costs and administrative burden, and decrease physician autonomy.